Our nursing staff at the cme event #nephcards2018
@drnupur_21 on NOACS and ckd #nephcards2018
@danielwross4 using polls to teach lvad and kidney #nephcards2018
David Majure on #lvad #nephcards2018
Special thanks to @jradnephro on cardiorenal syndrome #nephcards2018
Amazing talk on contrast nephropathy @PaulPalevsky #nephcards2018
Planning committee #nephcards2018
Chf management in ckd. #nephcards2018 www.ajkd.org/article/S0272-6386(18)30... @AJKDonline
@Renal_MD Thanks for your amazing end of talk summaries for #nephcards2018
#nephcards2018 #lvad #tavr @danielwross4
Special thanks @SLeonMD @KhurramKidney for live tweets for the conference #nephcards2018
#nephcards2018 Recent Perioperative Pharmacological Prevention of Acute Kidney Injury after Cardiac Surgery: A Narrative Review.
#nephcards2018 Acute Kidney Injury Associated with Cardiac Surgery
#nephcards2018 THE EVOLVING ROLE OF BIOMARKERS IN CARDIAC SURGERY ASSOCIATED AKI
#nephcards2018 Very important topic!
#nephcards2018 Risk stratification and testing algorithm
#nephcards2018 ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease:
#nephcards2018 Cardiac Disease Evaluation and Management Among
Kidney and Liver Transplantation Candidates
#nephcards2018 In a meta-analysis which included 28 studies (3931 patients), an elevated troponin T (> 0.1 ng/mL) identifies a subgroup of ESRD patients who have poor survival and a high risk of cardiac death despite being asymptomatic.
#nephcards2018 The renal patient with coronary artery disease: Current concepts and dilemmas
#nephcards2018 Cardiovascular Morbidity and Mortality in CKD Patients
#nephcards2018
Conclusion: anticoagulation of patients with severe CKD and ESRD remains a topic of debate. CKD increases the risk of both thromboembolism and hemorrhage. Decision to anticoagulate and choice of agent should be individualized.